Your browser doesn't support javascript.
loading
A novel inhibitor of Rho GDP-dissociation inhibitor α improves the therapeutic efficacy of paclitaxel in Lewis lung carcinoma.
Peng, Xing Chen; Chen, Xu Xia; Zhang, Y U; Wang, Hai Jun; Feng, You.
Afiliação
  • Peng XC; Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Chen XX; Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
  • Zhang YU; Department of Oncology, Guizhou Provincial People's Hospital, Guiyang, Guizhou 550000, P.R. China.
  • Wang HJ; Department of Thoracic Surgery, Sichuan Cancer Hospital, Chengdu, Sichuan 610041, P.R. China.
  • Feng Y; Department of Medical Oncology, Cancer Center, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China.
Biomed Rep ; 3(4): 473-477, 2015 Jul.
Article em En | MEDLINE | ID: mdl-26171151

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2015 Tipo de documento: Article